Ocado has embraced a significant shift in consumer needs by launching a range of food products designed specifically for customers using weight loss injections. Following the lead of retailers like Marks & Spencer, Co-op, and Morrisons, Ocado is now offering a “weight management” aisle featuring smaller portions and nutrient-dense items tailored to those managing their appetite with medication.
Among the new products is a “small steak” portion aimed at individuals seeking controlled servings. The selection also includes high-protein cottage cheese, simple two-ingredient beef burgers, and nutrient-rich Romesco chicken. Ocado and M&S are collaborating to provide items like the Huel ready-to-drink black edition chocolate 500ml, alongside meals such as pressed chicken teriyaki and turkey lentil Bolognese.
Charlie Parker, senior nutritionist at Ocado Retail, emphasized the growing importance of nutrition amid the increasing use of weight loss drugs. “As weight loss medications become more widely used, it’s crucial that diet and nutrition remain part of the conversation,” he said. Parker noted that many customers are actively seeking high-protein, high-fiber foods and balanced meals to support sustainable, healthier weight loss experiences, especially as these medications can reduce appetite.
READ MORE: DWP to Send Letters Announcing Pension and Benefit Increases to Retirees
READ MORE: Planners Set to Decide on Conversion of Former Willenhall Pub into 10-Bed HMO
This initiative comes shortly after a landmark study revealed that individuals who discontinue weight loss injections often regain lost weight within two years—a faster rate than those following other weight loss methods. Weight loss medications, known as GLP-1 agonists, were initially developed to treat diabetes. They work by mimicking the hormone glucagon-like peptide-1 (GLP-1), which promotes feelings of fullness.
Dr. Sam West from the Nuffield Department of Primary Care Health Sciences at the University of Oxford, who co-authored the study, commented: “These medicines are transforming obesity treatment and can achieve important weight loss. However, our research shows that people tend to regain weight rapidly after stopping – faster than we see with behavioural programmes.” He added, “This isn’t a failing of the medicines – it reflects the nature of obesity as a chronic, relapsing condition. It sounds a cautionary note for short-term use without a more comprehensive approach to long-term weight management, and highlights the importance of primary prevention.”